| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9348281 | Progress in Retinal and Eye Research | 2005 | 25 Pages |
Abstract
Intravitreal triamcinolone acetonide may offer a possibility for adjunctive treatment of intraocular edematous and neovascular disorders. One has to take into account the side-effects and the lack of long-term follow-up observations.
Related Topics
Life Sciences
Neuroscience
Sensory Systems
Authors
Jost B. Jonas, Ingrid Kreissig, Robert Degenring,